M2Select app analytics for 17 marzo

M2Select

M2Select

  • Rennova Health, Inc.
  • App Store di Apple
  • Gratis
  • Settore Medico
** M2Select requires a MedicalMime account. Contact us at support@medicalmime.com for more information ** M2Select is a powerful Electronic Health Record (EHR) app designed for facilities that specialize in: • Substance Abuse • Rehabilitation and Addiction • Behavioral and Mental Health From group sessions to client cell phone policies, M2Select features many tools and functions unique to substance abuse treatment and behavioral health — including detailed treatment and aftercare plans for dozens of specific diagnoses including substance abuse, depression, anxiety and anger management. M2Select’s specialized clinical workflow provides intuitive prompts for symptoms and enables you to quickly select problems and create master treatment plans with goals, objectives, and interventions. M2Select’s extensible library of forms and templates covers every aspect of patient care, including a full array of ASAM forms and customizable assessments.
M2Select

Classifica degli store

La classifica del store si basa su diversi parametri stabiliti da Google e Apple.

Tutte le categorie in
Stati Uniti--
Settore Medico in
Stati Uniti--
Crea un account per visualizzare il numero mensile medio di downloadContattaci

M2SelectStatistiche di ranking nel tempo

Classifica di Utilizzo di Similarweb e Classifica App Store di Apple per M2Select

Rank

Nessun dato disponibile

M2Select Classifica per paese

Paesi in cui M2Select ha la posizione più alta nelle sue categorie principali

Nessun dato da visualizzare

Principali concorrenti e app alternative

App con un'alta probabilità di essere utilizzate dagli stessi utenti, provenienti dallo stesso store.

Recovery Centers of Montana

Recovery Centers of Montana

Recovery Centers of Montana, LLC

EHNOTE Practice

EHNOTE Practice

EHNOTE SOFTLABS PRIVATE LIMITED

WISE-Touch

WISE-Touch

ModuleMD, LLC

EHRSynergy, LLC

EHRSynergy, LLC

EHRsynergy, LLC

M2Select VS.

marzo 17, 2025